Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Clinical Neurophysiologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
April 3, 2007
New device looks promising for improving motor function after stroke
Analysis of: MIT Brace Aids Stroke Recovery - Worn On The Arm, NeuroRobotic Device Is Lightweight, Portable | www.medicalnewstoday.com
Author: GLG Expert Contributor
  A new robotic brace developed by MIT researchers allows patients to have improved limb use by facilitating joint movement.
April 2, 2007
Vaccines
Analysis of: Vaccines: What Does Cervical Cancer Have To Do With Chickenpox? | blogs.wsj.com
Author: GLG Expert Contributor
The article discusses current problems with the apparent short life of the chicken pox vaccine and mandatory vaccinations.
April 2, 2007
Walmart investing in new healthcare IT center
Analysis of: Wal-Mart And Partners Create Health-IT Research Center | informationweek.com
Author: GLG Expert Contributor
Wal-Mart has teamed with the University of Arkansas and Blue Cross Blue Shield to create a new health IT research center Its goals are to reduce medical errors and increase the efficiency of health care supply.
April 2, 2007
Large need for vision testing according to CDC study
Analysis of: Study: Half of U.S. adults at high risk for vision loss not receiving eye exams | www.osnsupersite.com
Author: GLG Expert Contributor
30,000 people over age 18 surveyed Researchers estimated that 61 million Americans are at high risk for vision loss and, of these just more than 50% visited an eye doctor or had a dilated eye exam in the past year. African Americans and Hispanic persons were significantly less likely to visit an...
April 2, 2007
TB and HIV
Analysis of: Global Rate of TB Infections Levels Off | online.wsj.com
Author: GLG Expert Contributor
Global rates of TB infection appear to be leveling. AIDS associated and drug resistant forms of TB may be on the rise.
April 2, 2007
New FDA approval for Keppra (levetiracetam)
Analysis of: Keppra® Approved For US Epilepsy Patients With One Of The Most Debilitating Seizure Types | www.medicalnewstoday.com
Author: GLG Expert Contributor
Keppra has received FDA approval for adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy (IGE). This is Keppra’s third approved indication.
March 21, 2007
New alternative to multi-level fusions
Analysis of: Impliant Receives CE Mark Approval For The TOPS-on-Fusion(TM) System, The First Integrated Motion Preservation System For Spinal Fusion Patients | www.medicalnewstoday.com
Author: GLG Expert Contributor
The Impliant TOPS-on-Fusion (TM) device has received CE Mark approval.The system allows the surgeon to avoid fusing 2 levels.
March 20, 2007
New Rapid Viral Meningitis Test
Analysis of: FDA Clears Rapid Test for Meningitis | www.fda.gov
Author: GLG Expert Contributor
Bacterial meningitis is a life threating condition, which must be distinguished from the less serious viral meningitis.  The Xpert EV test has been approved by the FDA.
March 20, 2007
FDA warning on sleep medications
Analysis of: FDA Issues Warning on Sleeping Pills | www.nytimes.com
Author: GLG Expert Contributor
The article reports on a new FDA warning pertaining to prescription sleep medications.Medications to promote sleep are widely prescribed.New FDA warning could impact prescribing practices
March 20, 2007
perimenstrual migraine prophylaxis
Analysis of: U.S.extends review of Endo-Vernalis drug to August | today.reuters.com
Author: GLG Expert Contributor
FDA is evaluating Frova for  a new indicationThis could lead to more prescriptions for all triptansThis could improve Frova's market share

Previous Page : 1 2 3 4 5 Next31 to 40 of 46

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773